Pricing Log in Create free account

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs Jaguar Animal Health, Inc. (JAGX)

Chemomab Therapeutics Ltd. Sponsored ADR and Jaguar Animal Health, Inc. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and Jaguar Animal Health, Inc. are of similar size ($9.4M and $8.9M). Chemomab Therapeutics Ltd. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Chemomab Therapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (−247.4% vs −28,393.6%). Across the 14 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 9 and Jaguar Animal Health, Inc. on 5.

Valuation

Metric CMMB JAGX Biotechnology median
P/E n/m 0.00 8.50
P/S n/m 0.01 9.71
P/B 1.17 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.13 0.64
EV/Sales n/m (0.11) 9.21
Earnings yield (63.03%) 51,230.90% (33.15%)
Free cash flow yield (358.23%) (3,867.38%) (25.50%)

Profitability

Metric CMMB JAGX Biotechnology median
Gross margin 0.00% 82.31% 65.16%
Operating margin 0.00% (93.10%) 0.00%
Net margin 0.00% (188.46%) 0.00%
Free cash flow margin 0.00% (24.03%) 0.00%
Return on equity (82.17%) (1,125.38%) (56.36%)
Return on assets (70.70%) (127.14%) (48.04%)
Return on invested capital (247.40%) (28,393.64%) 0.00%

Growth

Metric CMMB JAGX Biotechnology median
Revenue growth (TTM) — 135.52% 6.02%
EPS growth (last fiscal year) 58.14% 82.42% 30.26%
Revenue growth, 5-year CAGR — 4.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB JAGX Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 6.41 0.69 4.72
Net debt to EBITDA 1.09 (0.17) 0.96

Dividend

Metric CMMB JAGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMMB JAGX Biotechnology median
Market cap 9.35m 8.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack